13D/13G Filings - Frazier Life Sciences VIII L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-05-21
10:21 am
Sale
2024-05-2013DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.0
0.000%
-6,090,980decrease
(Position Closed)
Filing
History
2024-04-29
6:08 pm
Purchase
2024-04-2513DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.6,090,980
9.300%
8,079increase
(+0.13%)
Filing
History
2024-03-06
12:40 pm
Purchase
2024-03-0413DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.8,862,478
7.800%
21,052increase
(+0.24%)
Filing
History
2023-11-22
10:25 am
Purchase
2023-11-2013DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.6,082,901
9.800%
2,918,793increase
(+92.25%)
Filing
History
2023-10-26
4:11 pm
Purchase
2023-10-2413DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.8,841,426
9.400%
96,108increase
(+1.10%)
Filing
History
2022-08-09
3:11 pm
Purchase
2022-08-0513DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.8,745,318
14.600%
263,411increase
(+3.11%)
Filing
History
2022-02-15
2:18 pm
Sale
2022-02-1113DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.3,164,108
10.800%
-13,734decrease
(-0.43%)
Filing
History
2022-01-28
1:39 pm
Purchase
2021-12-3113GSierra Oncology, Inc.
SRRA
Frazier Life Sciences VIII L.P.1,264,861
8.400%
1,062,058increase
(+523.69%)
Filing
History
2021-09-21
3:37 pm
Purchase
2021-09-1713DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.3,177,842
10.000%
440,741increase
(+16.10%)
Filing
History
2021-05-12
5:27 pm
Sale
2021-05-1013DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.8,481,907
16.900%
-2,084,883decrease
(-19.73%)
Filing
History
2021-05-04
12:31 pm
Purchase
2021-04-0513DAptinyx Inc.
APTX
Frazier Life Sciences VIII L.P.3,195,055
4.800%
4,976increase
(+0.16%)
Filing
History
2021-02-09
11:14 am
Purchase
2021-02-0513DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.10,566,790
21.700%
24,000increase
(+0.23%)
Filing
History
2021-02-04
4:37 pm
Sale
2020-11-1213DAptinyx Inc.
APTX
Frazier Life Sciences VIII L.P.3,190,079
5.100%
-50,037decrease
(-1.54%)
Filing
History
2020-10-06
2:42 pm
Unchanged
2020-10-0613DArcutis Biotherapeutics, Inc.
ARQT
Frazier Life Sciences VIII L.P.10,542,790
24.100%
0
(Unchanged)
Filing
History
2020-07-30
8:16 pm
Purchase
2020-07-2813DAlpine Immune Sciences, Inc.
ALPN
Frazier Life Sciences VIII L.P.2,737,101
11.500%
11,475increase
(+0.42%)
Filing
History
2020-06-18
12:30 pm
Sale
2020-06-1113DEntasis Therapeutics Holdings Inc.
ETTX
Frazier Life Sciences VIII L.P.799,953
2.900%
-250,000decrease
(-23.81%)
Filing
History